Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Deloitte Acquires Intrasphere Technologies | Contract Pharma

What are you searching for?

Sign in
Breaking News

Deloitte Acquires Intrasphere Technologies

Gains entry into drug safety and regulatory consulting market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Deloitte has acquired the assets of Intrasphere Technologies, Inc., a global drug safety and regulatory consulting business. Intrasphere, headquartered in Jersey City, NJ, with European headquarters in London, provides professional services to help life sciences companies improve product safety, signal intelligence, pharmacovigilance and regulatory information management capabilities. Terms of the acquisition were not disclosed.

The acquisition includes Intrasphere’s PharmaCM software that enables life sciences companies to register clinical trial information on government-mandated registries through workflow-enabled functionality that allows for content management and re-use. The PharmaCM product will be provided as a service offering within Deloitte Managed Analytics, which is led by Richard Cohen, principal, Deloitte Consulting LLP. This new business adds to Deloitte’s enterprise risk, security and regulatory compliance services, and additional business advisory services.

“We are excited about this important and strategic investment,” said Dan Ressler, principal, Deloitte Consulting LLP, who will lead Deloitte’s new drug safety and regulatory consulting business as part of his overall responsibilities in leading research and development informatics in life sciences. “The growing impact of health information technology and social media, greater complexity of therapeutic offerings in the marketplace, and an increasingly complex and stringent regulatory environment, in particular, have created an impetus for more proactive product safety and regulatory support services.”

“Deloitte’s broad-based relationships in life sciences give us access to clients where we don’t have a presence today. Moreover, our staff and leadership now have the opportunity to gain exposure to a variety of resources and opportunities as part of Deloitte,” said Bill Karl, co-founder and former chief executive officer of Intrasphere. Karl now joins Deloitte Consulting LLP as a director.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics